Drug Delivery
-
More Effective and Affordable Hepatitis Therapies Needed in Asia
China, Taiwan and South Korea represent endemic areas for viral hepatitis, with prevalence rates ranging from 4-13 percent for Hepatitis B (HBV) and from 1-4 percent for Hepatitis C (HCV). While there are several therapeutic options available fo…
Drug Delivery | 20 May 2010
-
Elga Launches Pulse Water Purification System
Elga, the global labwater brand of Veolia Water Solutions & Technologies has introduced a Type II (Electrodeionisation) EDI water purification system. The Purelab Pulse has been developed to produce consistently high purity water at economical runnin…
Drug Delivery | 17 May 2010
-
Bio/Pharmaceutical Cold Chain Management Asia
The third annual Bio/Pharmaceutical Cold Chain Management Asia conference was held from May 12-13 in Sentosa, Singapore. The event addressed the logistics challenges and issues that are faced by pharma companies today and offered solutions for more e…
Drug Delivery | 14 May 2010
-
Novartis Granted Pediatric Indication for Hypertension Treatment
The European Commission (EC) has granted Diovan (valsartan) a pediatric indication for the treatment of hypertension in children and adolescents 6-18 years of age. Following the Commission's decision, the pediatric indication needs to be implemented …
Drug Delivery | 13 May 2010
-
HealthLinx to Launch Cancer Diagnostic in Singapore
The HealthLinx OvPlex ovarian cancer diagnostic will be released in Singapore in July. Inex has the rights to distribute the diagnostic in Singapore, Thailand, Vietnam, Malaysia, Indonesia and India. The latter plans to use Singapore as the platf…
Drug Delivery | 06 May 2010
-
DHL Sees Growth in Asia’s Life Sciences Sector
DHL has seen a record number of movements of healthcare products in 2009 in Asia. Compared to 2008, shipment of finished pharmaceuticals, vaccines, medical equipment and devices and clinical trials facilitated by the company’s Life Sciences & Healt…
Drug Delivery | 05 May 2010
-
Branded Pharma Needs to Capitalize on Emerging Markets
With US$110 billion in global sales exposed to generic competition for the top 50 pharmaceutical companies through to 2014, branded pharma must look to emerging markets, biologics and continued cost-saving initiatives to drive growth according to Dat…
Drug Delivery | 05 May 2010
-
Nycomed and Merck & Co Announce Commercialization Agreements in Europe and Canada
Nycomed and Merck & Co have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas (roflumilast), an investigational once-daily tablet for patients with Chronic Obstructive Pulmonary Disease…
Drug Delivery | 29 April 2010
-
Healthcare in Asia: Keeping Pace
Healthcare in Asia was held in Singapore on March 30-31, to debate and explore the region’s healthcare challenges, and the priorities for reform. The event was attended by 200 visitors including healthcare ministers, policymakers and practitioners.…
Drug Delivery | 29 April 2010
-
Elder Pharmaceuticals to Increase Sales Force in India
With major thrust on the rural markets and plans to launch more products (owned and in-licensed) in FY 2011 across India, Elder Pharmaceuticals plans to increase its sales and marketing force headcount by about 1,000. Elder presently employs abou…
Drug Delivery | 23 April 2010
